Investors & News

Investor Relations

Webcast ImageWebcast
Ascendis Pharma at Wells Fargo Healthcare Conference 2017 (Live)
09/06/17 at 2:25 p.m. ET
Ascendis Pharma at Wells Fargo Healthcare Conference 2017
Wednesday, September 6, 2017 2:25 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Ascendis Pharma at the 2017 Wedbush PacGrow Healthcare Conference (Replay)
08/15/17 at 10:55 a.m. ET
Ascendis Pharma at the 2017 Wedbush PacGrow Healthcare Conference
Tuesday, August 15, 2017 10:55 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Q2 2017 Ascendis Pharma Earnings Conference Call (Replay)
08/18/17 at 8:00 a.m. ET
Q2 2017 Ascendis Pharma Earnings Conference Call
Friday, August 18, 2017 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Ascendis Pharma is a clinical stage biopharmaceutical company applying its TransCon technology to develop a pipeline of long-acting prodrug therapies with best-in-class profiles to address large markets with significant unmet medical needs.

Stock Information
ASND (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$27.27
Change (%)0.00 (0.00%)
Volume0
Data as of 08/21/17 3:59 p.m. ET
Refresh quote
Stock chart for: ASND.O.  Currently trading at $27.27 with a 52 week high of $31.86 and a 52 week low of $17.15.
Recent NewsMore >>
18/Aug/2017
Ascendis Pharma A/S Reports Second Quarter 2017 Financial Results
08/Aug/2017
Ascendis Pharma A/S Announces Upcoming Investor Presentations
03/Aug/2017
Ascendis Pharma A/S Announces Second Quarter 2017 Financial Results Conference Call on August 18
Upcoming EventsMore >>
Ascendis Pharma at Wells Fargo Healthcare Conference 2017
Wednesday, September 6, 2017 2:25 p.m. ET
LocationBoston, MA
Ascendis Pharma at Morgan Stanley Global Healthcare Conference 2017
Tuesday, September 12, 2017 9:10 a.m. ET
LocationNew York City, NY
Primary IR Contact
Scott T. Smith
Chief Financial Officer
Ascendis Pharma
E-mail: ir@ascendispharma.com

Data provided by Nasdaq. Minimum 15 minutes delayed.